Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
4Cast Systems is a precision medicine company that utilizes artificial intelligence to optimize cancer treatment selection. The company's proprietary platform analyzes a combination of genomic, clinical, and pathological data to predict how individual patients will respond to specific oncological therapies. This decision-support tool helps clinicians identify the most effective treatments while avoiding those likely to cause unnecessary toxicity without benefit. Based in Tel Aviv, Israel, 4Cast Systems works in collaboration with leading medical institutions to integrate its predictive models into standard clinical practice. The company's primary focus is on improving outcomes for patients with solid tumors, including breast and colorectal cancers. By leveraging machine learning, 4Cast Systems aims to transform the "trial and error" approach of oncology into a data-driven precision science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 4Cast Systems.